TY - JOUR
KW - Addiction
KW - Analgesics, Opioid/therapeutic use
KW - buprenorphine
KW - Buprenorphine, Naloxone Drug Combination
KW - Buprenorphine/therapeutic use
KW - Health Services Accessibility
KW - high threshold/low tolerance
KW - Humans
KW - identity
KW - medication-assisted treatment
KW - Methadone
KW - Methadone/therapeutic use
KW - Opiate Substitution Treatment/psychology
KW - opioid dependency
KW - Opioid-Related Disorders/drug therapy
KW - Patient Compliance
KW - Social Control, Formal
KW - Social Stigma
KW - Stigma
AU - K. McElrath
A1 - 
BT - Substance use & misuse
C5 - Opioids & Substance Use
CP - 2
CY - England
DO - 10.1080/10826084.2017.1342662
IS - 2
JF - Substance use & misuse
PP - England
PY - 2018
SN - 1532-2491; 1082-6084
SP - 334
EP - 343
EP - 
T1 - Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary
T2 - Substance use & misuse
TI - Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary
U1 - Opioids & Substance Use
U2 - 28862903
U3 - 10.1080/10826084.2017.1342662
VL - 53
VO - 1532-2491; 1082-6084
Y1 - 2018
ER -